Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 28Dermatologic 5Thoracic 4Breast 3Gynecologic 2Genitourinary 2Gastrointestinal 2CNS 2Sarcoma 1Other neoplasm 1NET 1Endocrine 1

Conditions

Precancerous Conditions 12Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 3Esophageal Neoplasms 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Tongue Neoplasms 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Mouth Neoplasms 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Leukoplakia, Oral 1Laryngeal Neoplasms 1Keratosis, Actinic 1

Interventions

Radiotherapy, Intensity-Modulated 2Cisplatin 2Cetuximab 2vandetanib 1Video-Assisted Surgery 1Photochemotherapy 1Paclitaxel 1Immunohistochemistry 1Gene Expression Profiling 1Dihematoporphyrin Ether 1Comparative Genomic Hybridization 1Biopsy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Biopsy × Other neoplasm × Clear all
NCT01414426 2021-01-14

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

University of Chicago

Phase 2 Completed
20 enrolled 7 charts
Head & NeckOther neoplasm

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡